Literature DB >> 18774270

Facial emotion recognition and its relationship to symptomatic, subjective, and functional outcomes in outpatients with chronic schizophrenia.

Alex Hofer1, Cord Benecke, Monika Edlinger, Regina Huber, Georg Kemmler, Maria A Rettenbacher, Gerald Schleich, W Wolfgang Fleischhacker.   

Abstract

Outcome in schizophrenia is multidimensional and consists of clinical and psychosocial domains. Difficulties in affect recognition are a hallmark of schizophrenia, but there is little research investigating the consequences of this deficit on patients' psychosocial status. This cross-sectional study examined the relationship of facial affect recognition and treatment outcomes in terms of psychopathology, quality of life (QOL), and psychosocial functioning. We investigated 40 regular attendees of a specialized schizophrenia outpatient clinic who had been stable both from a symptomatic and a medication perspective for a minimum of 6 months and 40 healthy volunteers who were chosen to match patients in age, sex, and education. Affect recognition was positively associated with patients' level of education and negatively with increasing age. Deficits in this area corresponded to the severity of negative and affective symptoms as well as to poor work and global functioning. These findings suggest that affect recognition is an important aspect of psychosocial functioning in stable outpatients with schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18774270     DOI: 10.1016/j.eurpsy.2008.06.008

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  19 in total

1.  Temporal lobe structures and facial emotion recognition in schizophrenia patients and nonpsychotic relatives.

Authors:  Vina M Goghari; Angus W Macdonald; Scott R Sponheim
Journal:  Schizophr Bull       Date:  2010-05-19       Impact factor: 9.306

2.  A meta-analysis of emotion perception and functional outcomes in schizophrenia.

Authors:  Farzin Irani; Sarah Seligman; Vidyulata Kamath; Christian Kohler; Ruben C Gur
Journal:  Schizophr Res       Date:  2012-02-15       Impact factor: 4.939

3.  Neural markers of emotional face perception across psychotic disorders and general population.

Authors:  Amri Sabharwal; Roman Kotov; Akos Szekely; Hoi-Chung Leung; Deanna M Barch; Aprajita Mohanty
Journal:  J Abnorm Psychol       Date:  2017-05-29

4.  The Change in Facial Emotion Recognition Ability in Inpatients with Treatment Resistant Schizophrenia After Electroconvulsive Therapy.

Authors:  Mihriban Dalkıran; Akif Tasdemir; Tamer Salihoglu; Murat Emul; Alaattin Duran; Mufit Ugur; Ruhi Yavuz
Journal:  Psychiatr Q       Date:  2017-09

5.  Facial Feedback and Social Input: Effects on Laughter and Enjoyment in Children with Autism Spectrum Disorders.

Authors:  Molly S Helt; Deborah A Fein
Journal:  J Autism Dev Disord       Date:  2016-01

6.  Effects of nicotine on social cognition, social competence and self-reported stress in schizophrenia patients and healthy controls.

Authors:  Katharina Drusch; Agnes Lowe; Katrin Fisahn; Jürgen Brinkmeyer; Francesco Musso; Arian Mobascher; Tracy Warbrick; John Shah; Christian Ohmann; Georg Winterer; Wolfgang Wölwer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-10-19       Impact factor: 5.270

7.  Psychophysical measures of sensitivity to facial expression of emotion.

Authors:  Michelle Marneweck; Andrea Loftus; Geoff Hammond
Journal:  Front Psychol       Date:  2013-02-20

8.  Is There Any Relation Between Impaired Emotion Perception and Thought Disorder in Schizophrenia?

Authors:  Elif Yildirim; Berna Yalinçetin; Şilay Sevilmiş; Özge Kutay; Köksal Alptekin
Journal:  Noro Psikiyatr Ars       Date:  2018-05-04       Impact factor: 1.339

9.  Yoga therapy for Schizophrenia.

Authors:  N Gangadhar Bangalore; Shivarama Varambally
Journal:  Int J Yoga       Date:  2012-07

10.  Facial emotion recognition in schizophrenia: the impact of gender.

Authors:  Almıla Erol; Gulperi Putgul; Ferdi Kosger; Bilal Ersoy
Journal:  Psychiatry Investig       Date:  2013-01-25       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.